Evidence map›Paper›PMID 37094230›Full record

ArticleOrganic letters2024

Redefining the Synthetic Logic of Medicinal Chemistry. Photoredox-Catalyzed Reactions as a General Tool for Aliphatic Core Functionalization.

David F Fernández, María González-Esguevillas, Sebastian Keess, Felix Schäfer, Jens Mohr, Andre Shavnya, Thomas Knauber, David C Blakemore, David W C MacMillan

Abstract read
In one paragraph

Article in Organic letters, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Regiodivergent α- and β-Functionalization of SaturatedJournal of the American Chemical Society · 2025
    Article
  7. Journal of the American Chemical Society · 2025
    Article
  8. C(spACS catalysis · 2025
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

David F FernándezMerck Center for Catalysis, Princeton University, Princeton, New Jersey 08544, United States.ORCID 0000-0003-3482-0894
María González-EsguevillasMerck Center for Catalysis, Princeton University, Princeton, New Jersey 08544, United States.ORCID 0000-0003-3779-5516
Sebastian KeessMerck Center for Catalysis, Princeton University, Princeton, New Jersey 08544, United States.ORCID 0000-0002-0791-6877
Felix SchäferMerck Center for Catalysis, Princeton University, Princeton, New Jersey 08544, United States.
Jens MohrMerck Center for Catalysis, Princeton University, Princeton, New Jersey 08544, United States.
Andre ShavnyaPfizer Worldwide Research and Development, Pfizer Inc., Eastern Point Road, Groton, Connecticut 06340, United States.
Thomas KnauberPfizer Worldwide Research and Development, Pfizer Inc., Eastern Point Road, Groton, Connecticut 06340, United States.ORCID 0000-0002-3354-3322
David C BlakemorePfizer Worldwide Research and Development, Pfizer Inc., Eastern Point Road, Groton, Connecticut 06340, United States.
David W C MacMillanMerck Center for Catalysis, Princeton University, Princeton, New Jersey 08544, United States.ORCID 0000-0001-6447-0587

Funding

Photoredox Catalysis Applications in Organometallics and Chemical BiologyR35GM134897 · NIGMS · PRINCETON UNIVERSITY · PI David W MacMillan · 2020 to 2026
$6.3M
NIGMS NIH HHS R35 GM134897
6 · The paper itself

Abstract

C(sp

Indexed as

Chemistry, PharmaceuticalCatalysis

Identifiers

PMID37094230
PMCPMC10680136

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.